Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: A double-blind placebo-controlled trial

Osteoporosis International

Volumn 17, Issue 10, 2006, Pages 1546-1551

  McDonald, C F ^a   Zebaze, R M D ^a   Seeman, E ^a  

^a AUSTIN HOSPITAL   (Australia)

Author keywords

Asthma; Calcitriol; Glucocorticoids; Osteoporosis

Indexed keywords

BECLOMETASONE DIPROPIONATE; CALCITRIOL; CORTICOSTEROID; GLUCOCORTICOID; PLACEBO;

ADULT; AGED; ARTICLE; ASTHMA; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FRACTURE; HUMAN; LUMBAR SPINAL CORD; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

ADMINISTRATION, INHALATION; ASTHMA; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CALCITRIOL; DOUBLE-BLIND METHOD; FEMALE; FEMUR NECK; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 33748673547     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-006-0158-2     Document Type: Article

References (41)

1. Lukert B (1996) Glucocorticoid-induced osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds). Osteoporosis. Academic Press, San Diego, pp 801-820
2. Adinoff AD, Hollister JR (1983) Steroid induced fractures and bone loss in patients with asthma. New Engl J Med 309:265-268
3. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS (2001) Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 345:941-947
4. Suissa S, Baltzan M, Kremer R and Ernst P (2004) Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 169:83-88
5. Dykman TR, Haralson KM, Gluck OS et al (1984) Effect of oral, 1.25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 27:1336-1343
6. α - (OH)D3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment: a double blind controlled study. Clin Endocrinol (Oxf) 19:265-273
7. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute (1997) Expert panel report 2: guidelines for the diagnosis and management of asthma. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda
8. Barnes NC, Marone G, Di Maria U, Visser S, Utama I, Payne SL (1993) A comparison of fluticasone propionate 1 mg daily with beclomethasone dipropionate 2 mg daily in the treatment of severe asthma. Eur Respir J 6:877-885
9. Ayres JG, Bateman ED, Lundback B, Harris TA (1995) High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. Eur Respir J 8:579-586
10. Andrew JV (2001) The use of percentage change from baseline as an outcome in controlled trial is statistically inefficient: a simulation study. BMC Med Res Methodol 1:6
11. Van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777-787
12. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S (1995) Dose-related decreases in bone density among asthmatic patients treated with inhaled corticosteroid. J Allergy Clin Immunol 96:571-579
13. Ip M, Lam K, Yam L, Kung A, Ng M (1994) Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 105:1722-1727
14. Packe GE, Douglas JG, McDonald AF, Robins SP, Reid DM (1992) Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 47:414-417
15. Laatikainen AK, Kroger HPJ, Tukinainen HO, Honkanen RJ, Saarikoski SV (1999) Bone mineral density in perimenopausal women with asthma: a population-based cross-sectional study. Am J Respir Crit Care Med 159:1179-1185
16. Ebeling PR, Erbas B, Hopper JL, Wark JD, Rubinfeld AR (1998) Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. J Bone Min Res 13:1283-1289
17. Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Nanes MS (1999) Declining bone mass in men with chronic obstructive pulmonary disease: contribution of glucocorticosteroid treatment, body mass index, and gonadal function. Chest 116:1616-1624
18. Hughes JA, Conry BG, Male SM, Eastell R (1999) One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density. Thorax 54:223-229
19. Boulet LP, Giguère MC, Milot J, Brown J (1994) Effects of long-term use of high dose inhaled steroid on bone density and calcium metabolism. J Allergy Clin Immunol 94:796-803
20. Boulet LP, Milot J, Gagnon L, Puobelle PE, Brown J (1999) Long-term influence of inhaled corticosteroids on bone metabolism and density: are biological markers predictors of bone loss? Am J Respir Crit Care Med 159:838-844
21. Luengo M, Del Rio L, Pons F, Picado C (1997) Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study. Eur Respir J 10:2110-2113
22. Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G (2002) Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev (1):CD003537
23. The Lung Health Study Research Group (2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 343:1902-1090
24. Richy F, Bousquet J, Ehrlich GE, Meunier PJ, Israel E, Morii H, Devogelaer J-P, Peel N, Haim M et al (2003) Inhaled corticosteroid effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporos Int 14:179-190
25. Hubbard RB, Smith CJP, Smeeth L, Harrison TW, Tattersfield AE et al (2002) Inhaled corticosteroids and hip fracture. A population-based case-control study. Am J Respir Crit Care Med 166:1563-1566
26. Matsumoto H, Ishihara K, Hasegawa T, Umeda B, Niimi A, Hino M (2001) Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients. Chest 120:1468-1473
27. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J (1993) Prevention of corticosteroid osteoporosis-a comparison of calcium, calcitriol and calcitonin. New Engl J Med 328:1747-1752
28. Shane E, Addesso V, Namerow PB, McMahon DJ, Shaw-Hwa L, Staron RB, Zucker M, Pardi S, Maybaum S, Mancini D (2004) Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. New Engl J Med 350:767-776
29. Tilyard MW, Spears GFS, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. New Engl J Med 326:357-362
30. Falch JA, Odegaard OR, Finnanger M, Matheson I (1987) Postmenopausal osteoporosis: no effect of three years treatment with 1,25- dihydroxycholecalciferol. Proc Soc Exp Biol Med 191:199-204
31. Ott SM, Chestnut CH III (1989) Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 110:267-274
32. Christiansen C, Christensen MS, Rodbro P, Hagen C, Transbol I (1981) Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis. Eur J Clin Invest 11:305-309
33. Jensen GF, Christiansen C, Transbol I (1982) Treatment of postmenopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitaminD3 and calcium. Clin Endocrinol 16:515-524
34. Gallagher JC, Goldgar D (1989) Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. Ann Intern Med 113:649-655
35. Aloia JF, Vaswani A, Yeh JK, Yasumura S, Cohn SH (1988) Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 84:401-408
36. 3 accelerate spinal bone loss? Clin Orthop 192:215-221
37. Ebeling PR, Wark JD, Yeung S, Poon C, Salehi N, Nicholson GC, Kotowicz MA (2001) Effects of calcitriol or calcium on bone mineral density, bone turnover and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study. J Clin Endocrinol Metab 86:4098-4103
38. Gallagher JC, Riggs BL, Recker RR, Goldgar D (1989) The effect of calcitriol on patients with postmenopausal osteoporosis with special refence to fracture frequency. Proc Soc Exp Biol Med 191:287-291
39. Mirzaei S, Zajicek HK, Knoll P, Hahn M, Levi M, Kohn H, Pohl W (2003) Effect of rocaltrol on bone mass in patients with pulmonary disease treated with corticosteroids. J Asthma 40:251-255
40. Smith MD, Cheah SP, Taylor K, Ahern M (2001) Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital. J Rheumatol 28:566-570
41. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 44(7):1496-1503